Immunopsychiatry - Innovative Technology to Characterize Disease Activity in Autoantibody-Associated Psychiatric Diseases
- PMID: 35711412
- PMCID: PMC9197207
- DOI: 10.3389/fimmu.2022.867229
Immunopsychiatry - Innovative Technology to Characterize Disease Activity in Autoantibody-Associated Psychiatric Diseases
Abstract
Background: Anti-neural autoantibody-associated psychiatric disease is a novel field in immunopsychiatry that has been attracting attention thanks to its potentially positive therapeutic outcome and distinct prognosis compared with non-organic psychiatric disease. This review aims to describe recent novel technological developments for improving diagnostics in the field of autoantibody-related psychiatric disease.
Methods: We screened for relevant articles in PubMed for this narrative article. We focused on research methods such as neuroimaging, immune cells and inflammation markers, and molecular biomarkers in human biofluids like serum and cerebrospinal fluid and plasma proteomics.
Results: We introduce several novel methods for investigating autoinflammation with the aim of optimizing therapies for autoantibody-associated psychiatric disease. We describe measuring the translocator protein 18kDa in activated microglia via positron emission tomography imaging, brain volumetric assessment, flow cell cytometry of cerebrospinal fluid and blood, and blood biological probes as well as psychopathological cues to help us gain insights into diagnosing inflammation and brain damage better in psychiatric patients presenting a suspected autoimmune etiology.
Conclusion: Our short methodological review provides an overview of recent developments in the field of autoantibody-related immunopsychiatry. More research is needed to prove their usefulness in diagnosing and treating autoantibody-associated psychiatric disease and its subtypes.
Keywords: anti-neural autoantibody; autoimmunity; immunopsychiatry; innovative technology; methods.
Copyright © 2022 Hansen.
Conflict of interest statement
The author declares that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
Similar articles
-
Repositioning synthetic glucocorticoids in psychiatric disease associated with neural autoantibodies: a narrative review.J Neural Transm (Vienna). 2023 Aug;130(8):1029-1038. doi: 10.1007/s00702-022-02578-2. Epub 2022 Dec 28. J Neural Transm (Vienna). 2023. PMID: 36576564 Free PMC article. Review.
-
Autoantibody-associated psychiatric symptoms and syndromes in adults: A narrative review and proposed diagnostic approach.Brain Behav Immun Health. 2020 Oct 1;9:100154. doi: 10.1016/j.bbih.2020.100154. eCollection 2020 Dec. Brain Behav Immun Health. 2020. PMID: 34589896 Free PMC article.
-
Autoantibody-associated psychiatric syndromes in children: link to adult psychiatry.J Neural Transm (Vienna). 2021 Jun;128(6):735-747. doi: 10.1007/s00702-021-02354-8. Epub 2021 May 31. J Neural Transm (Vienna). 2021. PMID: 34057596 Free PMC article. Review.
-
Psychopathology of psychiatric patients presenting autoantibodies against neuroglial antigens.Front Psychiatry. 2022 Nov 10;13:945549. doi: 10.3389/fpsyt.2022.945549. eCollection 2022. Front Psychiatry. 2022. PMID: 36440415 Free PMC article.
-
Biomarkers of neurodegeneration in neural autoantibody-associated psychiatric syndromes: A retrospective cohort study.J Transl Autoimmun. 2022 Oct 5;5:100169. doi: 10.1016/j.jtauto.2022.100169. eCollection 2022. J Transl Autoimmun. 2022. PMID: 36238527 Free PMC article.
Cited by
-
Involvement of inflammatory responses in the brain to the onset of major depressive disorder due to stress exposure.Front Aging Neurosci. 2022 Jul 22;14:934346. doi: 10.3389/fnagi.2022.934346. eCollection 2022. Front Aging Neurosci. 2022. PMID: 35936767 Free PMC article. Review.
-
Evaluating Microglial Dysfunction and Psychiatric Illness by Exploring the Inflammatory Basis of Schizophrenia and Depression in Cross-Sectional Study settings.Cureus. 2025 Apr 23;17(4):e82831. doi: 10.7759/cureus.82831. eCollection 2025 Apr. Cureus. 2025. PMID: 40416228 Free PMC article.
References
-
- Pollak TA, Lennox BR, Müller S, Benros ME, Prüss H, Tebartz van Elst L, et al. . Autoimmune Psychosis: An International Consensus on an Approach to the Diagnosis and Management of Psychosis of Suspected Autoimmune Origin. Lancet Psychiatry (2020) 7:93–108. doi: 10.1016/S2215-0366(19)30290-1 - DOI - PubMed
-
- Endres D, Lüngen E, Hasan A, Kluge M, Fröhlich S, Lewerenz J, et al. . Clinical Manifestations and Immunomodulatory Treatment Experiences in Psychiatric Patients With Suspected Autoimmune Encephalitis: A Case Series of 91 Patients From Germany. Mol Psychiatry (2022. c). doi: 10.1038/s41380-021-01396-4 - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical